CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project is focused on developing a novel gene regulation system for treating neurodegenerative diseases like Parkinson's. It aims to enable controlled gene therapy, personalizing treatment for patients and enhancing safety.
Development of advanced therapeutics based on non-small molecule drugs for brain diseases is an area of intense research.
Experimental work using viral vector-mediated in vivo gene therapy showed great potential as a competitive therapeutic strategy for clinical use in neurodegenerative diseases. AAV vectors are now in early clinical trials stage for treatment of Parkinson’s disease.
Although it is deemed very important to have controlled expression in the brain, none of the currently tested str…
MAX IV Laboratory, Lund University
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Sweden, LUND
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
